Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Chengchuang Pharmaceutical Technology Development is a China-based pharmaceutical company focused on the research, development, and commercialization of innovative small molecule drugs. The company maintains a diverse pipeline targeting metabolic diseases, psychiatric disorders, and inflammatory conditions. Key areas of expertise include the development of high-end generic drugs and novel chemical entities (NCEs) with improved safety and efficacy profiles. Shandong Chengchuang operates integrated R&D facilities and provides contract research services alongside its internal drug development programs. The company aims to address significant unmet medical needs in the Chinese market and beyond through rigorous scientific innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Chengchuang Pharmaceutical Technology Development.